<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02180568</url>
  </required_header>
  <id_info>
    <org_study_id>SEV2013-0740</org_study_id>
    <secondary_id>F015894</secondary_id>
    <nct_id>NCT02180568</nct_id>
  </id_info>
  <brief_title>Lipiodol Localization for Ground-glass-opacity Minimal Surgery</brief_title>
  <acronym>LOGIS</acronym>
  <official_title>Validation Study to Evaluate the Safety and Efficacy of Preoperative Computed Tomography-guided Localization Technique Using Lipiodol for Patients With Ground Glass Opacity Pulmonary Lesions: A Prospective Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dankook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wonju Severance Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study object is to demonstrate the usefulness and safety of lipiodol localization
      technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic
      surgery (VATS) resection compared to hook wire localization technique. A total of 250
      participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims
      of this study are achieved, the use of lipiodol localization technique will be widespread
      their application for localization of non-palpable pulmonary lesions that are indicated for
      VATS resection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure success rate</measure>
    <time_frame>one day</time_frame>
    <description>Procedure success was defined as marking (lipiodol or hook-wire) the GGO lesion within 1 cm without pleural leakage of lipiodol or dislodgement of the hook-wire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>one day</time_frame>
    <description>Procedure-related complications such as pneumothorax, lung hemorrhage, hemoptysis, air-embolism and death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure time</measure>
    <time_frame>1 hour</time_frame>
    <description>Total procedure time for lung localization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery time</measure>
    <time_frame>12 hours</time_frame>
    <description>Surgery time for obtaining wedge resection specimen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety resection margin</measure>
    <time_frame>1 hour</time_frame>
    <description>The safety specimen resection margin was categorized either as positive (grossly positive (R2), microscopically positive if tumor was at the inked surface (R1)), or negative (microscopically negative if there was no tumor at the inked surface (R0))</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Pulmonary Lesion With Ground-glass-opacity</condition>
  <arm_group>
    <arm_group_label>Lipiodol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lipiodol-guided lung localization technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hookwire</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hookwire-guided lung localization technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lipiodol</intervention_name>
    <description>Lipiodol-guided lung localization technique</description>
    <arm_group_label>Lipiodol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hookwire</intervention_name>
    <description>Hookwire-guided lung localization technique</description>
    <arm_group_label>Hookwire</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lipiodol</intervention_name>
    <arm_group_label>Lipiodol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consenting adult patients â‰¥ 20 years of age

          -  Pulmonary lesion with a ground glass opacity(GGO)component of more than 50%

          -  Patient with lesion size less than 3cm

          -  Persistence or growth of the established lesion within a three month period

          -  Patient who are not contraindicated to surgery

          -  Patients who are willing to sign the informed consent form

        Exclusion Criteria:

          -  Patients with solid pulmonary lesion

          -  Patients with multiple GGOs need multiple localization

          -  Patients who are contraindicated to surgery

          -  Patients who behave in an uncooperative manner

          -  Unwilling or unable to give informed consent

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin Hur, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yonsei University Health System, Severance Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yonsei University Health System, Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2014</study_first_submitted>
  <study_first_submitted_qc>July 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2014</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>Jin Hur</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Ground-glass-opacity (GGO)</keyword>
  <keyword>Lung localization</keyword>
  <keyword>Lipiodol</keyword>
  <keyword>Hook wire</keyword>
  <keyword>Video assisted thoracic surgery (VATS)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethiodized Oil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

